Table VII.
Association between the expression of AP000459 and clinicopathological characteristics of gastric cancer patients.
| Variable | Cases, n (%) | Expression of AP000459 2−ΔΔCq (mean ± standard deviation) | P-value |
|---|---|---|---|
| Gender | 0.556 | ||
| Male | 59 (72) | −14.210±28.921 | |
| Female | 23 (28) | −9.352±36.174 | |
| Age, years | 0.497 | ||
| ≤50 | 30 (37) | −10.731±27.139 | |
| >50 | 52 (63) | −6.491±22.496 | |
| Tumor size, cm | 0.531 | ||
| ≤5 | 43 (52) | −15.297±30.456 | |
| >5 | 39 (48) | −10.649±31.745 | |
| Degree of differentiation | 0.861 | ||
| Well/moderately | 28 (34) | −11.958±27.352 | |
| Poorly | 54 (66) | −13.322±33.011 | |
| TNM stage | 0.924 | ||
| I/II | 44 (54) | −13.403±27.846 | |
| III/IV | 38 (46) | −12.689±36.611 | |
| Lymph node status | 0.662 | ||
| No metastasis | 36 (44) | −14.864±30.097 | |
| Metastasis | 46 (56) | −11.601±31.939 |
TNM, tumor-node-metastasis.